Physiomics Share Discussion Threads

[davevt] 18/12/2020 10:31

Dubian, not sure if you're aware, but pyc only does dose prediction for known working cancer drugs only...that go through millions of dollars of trials..

All of the customers are, or are spin offs of multi billion dollar companies.

It's not like people are knocking up cancer drugs in their shed.

It's like saying you're a car airbags designer, and going 'wow, they work for a billion dollar car company'..

That's EXACTLY their target customer. Who else needs airbags designing..

[the stigologist] 18/12/2020 09:51

Snippets from Hybridan Research Note earlier this week

[langland] 18/12/2020 09:50

The consideration for the acquisition of Doseme was $20mn so PYC fits the ballpark for another acquisition at at least double the current mkt. cap.

[yoda5442] 18/12/2020 09:33

In 2018 PYC's new partner TRHC bought DoseMe, the developer of DoseMeRx, an advanced precision dosing tool to help physicians and pharmacists accurately dose patients’ high-risk parenteral medications based on individual needs.

Do they have intentions to buy PYC at some stage?

[dubian99] 18/12/2020 09:33

And do you think those billion $ pharms reached that status by not evolving and creating IP licences that capture markets and scalability after years of design, or why would anyone bother moron

[dubian99] 18/12/2020 09:22

Name one innovating billion dollar company anywhere that didn't start as a million dollar company

[davevt] 18/12/2020 09:17

I really wish the morons would stop talking about billion dollar tie ups. Name one large pharmaceutical company that isn't a billion dollar company 😂

[maddie275] 18/12/2020 09:05

Well, when it gets below 7.1 at least I can average down..!!!
Criminal..!!

[dubian99] 18/12/2020 08:46

Stake building going on here for sure certainly crossed the rubicon after rns, partnering 2 billion dollar pharms, then look at Prem no mine no money in Zimbabwe 9 mcap

[hodhasharon] 18/12/2020 08:44

Thanks for your input albert......what's that German word again?

[maddie275] 18/12/2020 08:40

Stunned silence..!
What a disappointment after yesterday.
No doubt, many ‘spiked’ above this level.
And the rest of us watching our profit trickle down the drain. (Or, pour, more accurately).
Exhausting..!!!

[letmepass] 18/12/2020 08:38

Another twitter ramp fest

[tmmalik] 18/12/2020 07:26

This morning RNS.Zahid put more money again ,race to acquire more share should continue throughout q1 2021.As soon as commercial agreement which should be at the end of Q1 ,sp should be above 20p and this every year spike should get stable this year.I don't think we will see single digit share price next year again .Dyor.

[doc robinson] 18/12/2020 07:25

Stake building RNS !

[the stigologist] 17/12/2020 23:29

Just filter the trolls owenga

This weeks Hybridan note is worth a read. Will try to stick it up / snippets tomorrow or the weekend so everybody can have a good leisurely read

It explains the potential very well

[davevt] 17/12/2020 22:44

The historical chart is pre multiple dilutions you utter idiot!

And back when pyc was more relevant and not left in the dust by all it's competitors...ironically the ones you keep mentioning..

Totally irrelevant 😂

Btw..'Remember this is Trial stage so no commercial terms mentioned but a $1bn US Company with $300m annual revenue is not going to be messing around'....it's totally irrelevant the revenues of a client....pyc are the ones that set the charge for trials, and we know what they are.

Last time I checked Merck do even more than a billion, but once again, 35k for a pre clinical trial, 120 for clinical, per cancer drug.

Pyc are only trialing one drug. One.

[the stigologist] 17/12/2020 22:38

I think 100p+ is more closer to reality now than ever. Note the historical chart and propensity for spikes to 100p+

But this time i think sustainably so

Remember this is Trial stage so no commercial terms mentioned but a $1bn US Company with $300m annual revenue is not going to be messing around. I fully expect we will see revenues and more importantly profit go thru the roof now. We were already close to breakeven now we have a US Company selling our IP thru their distribution network all the ingredients for hyper growth.

Will Tabula Rasa take a strategic equity stake in us to protect their investment ?

I think we'll be talking 20p+ for any such stake

[avsome1968] 17/12/2020 21:57

Wow wasn't expecting this patience's finally rewarded, well done stig bought in here a while ago 6.60p with your tip, thought it was looking rather bleak at one point what a great turn around, would like to take a bit of profit of the table tomorrow we shall see well done to all those that held their nerve with the constant negative posts from a few here for days on end.

[rolaw1] 17/12/2020 21:12

Appreciate the response davevt

[davevt] 17/12/2020 20:21

Nah, There will be lots of sellers itching to get out from the last spike.

That's the problem with this share, too many people trapped in at too many levels.

Too much ramping on this company.

[inv] 17/12/2020 20:21

Could be 15-20p on Friday